|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 343171-343180 of 2348570 (234857 Page(s) Totally)
<< < 34313 34314 34315 34316 34317 34318 34319 34320 34321 34322 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2016 |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
Huang, Chao-Yuan; Tai, Wei-Tien; Wu, Szu-Yuan; Shih, Chih-Ting; Chen, Min-Hsuan; Tsai, Ming-Hsien; Kuo, Chiung-Wen; Shiau, Chung-Wai; Hung, Man-Hsin; Chen, Kuen-Feng; 黃昭源; 陳昆鋒 |
| 元培科技大學 |
2016-06 |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
郭瓊文 |
| 臺大學術典藏 |
2020-02-10T09:00:23Z |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
Huang, Chao-Yuan; Tai, Wei-Tien; Wu, Szu-Yuan; Shih, Chih-Ting; Chen, Min-Hsuan; Tsai, Ming-Hsien; Kuo, Chiung-Wen; Shiau, Chung-Wai; Hung, Man-Hsin; Chen, Kuen-Feng; MONG-HSUN TSAI |
| 臺大學術典藏 |
2021-05-18T08:20:15Z |
Dovitinib acts as a novel radiosensitizer in hepatocellular carcinoma by targeting SHP-1/STAT3 signaling
|
CHAO-YUAN HUANG; Tai W.-T.; Wu S.-Y.; Shih C.-T.; Chen M.-H.; Tsai M.-H.; Kuo C.-W.; Shiau C.-W.; Hung M.-H.; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:03Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; ANN-LII CHENG; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; Chen P.-J.; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; Chen P.-J.; ANN-LII CHENG |
| 臺北醫學大學 |
2014 |
Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
|
Gaur, S;Chen, L;Ann, V;Lin, WC;Wang, Y;Chang, VH;Hsu, NY;Shia, HS;Yen, Y |
| 臺北醫學大學 |
2014-02-04 |
Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
|
Gaur, Shikha; Chen, Linling; Ann, Vincent; Lin, Wei-Chen; Wang, Yafan; Chang, Vincent HS; Hsu, Nan Yong; Shia, Her-Shuyong; Yen, Yun |
Showing items 343171-343180 of 2348570 (234857 Page(s) Totally)
<< < 34313 34314 34315 34316 34317 34318 34319 34320 34321 34322 > >>
View [10|25|50] records per page
|
